VEGF levels in patients with glioma: a systematic review and meta-analysis H Seyedmirzaei, P Shobeiri, M Turgut, S Hanaei, N Rezaei Reviews in the Neurosciences 32 (2), 191-202, 2021 | 41 | 2021 |
Brain-based sex differences in depression: a systematic review of neuroimaging studies S Mohammadi, H Seyedmirzaei, MA Salehi, A Jahanshahi, SS Zakavi, ... Brain Imaging and Behavior 17 (5), 541-569, 2023 | 32 | 2023 |
IL-6 and TNF-α responses to acute and regular exercise in adult individuals with multiple sclerosis (MS): a systematic review and meta-analysis P Shobeiri, H Seyedmirzaei, N Karimi, F Rashidi, AL Teixeira, S Brand, ... European Journal of Medical Research 27 (1), 185, 2022 | 26 | 2022 |
The epidemiology of brain and spinal cord tumors P Shobeiri, H Seyedmirzaei, A Kalantari, E Mohammadi, N Rezaei, ... Human Brain and Spinal Cord Tumors: From Bench to Bedside. Volume 1 …, 2023 | 20 | 2023 |
Neurite orientation dispersion and density imaging in multiple sclerosis: a systematic review H Seyedmirzaei, F Nabizadeh, MH Aarabi, L Pini Journal of Magnetic Resonance Imaging 58 (4), 1011-1029, 2023 | 13 | 2023 |
Efficacy and safety of rituximab in multiple sclerosis: a systematic review and meta-analysis F Nabizadeh, M Asghari Ahmadabad, M Mohamadi, O Mirmosayyeb, ... Acta Neurologica Belgica, 2023 | 13* | 2023 |
White matter tracts associated with alexithymia and emotion regulation: a diffusion MRI study H Seyedmirzaei, M Shafie, A Kargar, A Golbahari, M Bijarchian, S Ahmadi, ... Journal of Affective Disorders 314, 271-280, 2022 | 13 | 2022 |
Cytokine alterations in psoriasis: An updated review H Seyedmirzaei, N Rezaei Expert Review of Clinical Immunology 17 (12), 1323-1335, 2021 | 10 | 2021 |
White matter microstructural changes in internet addiction disorder: A systematic review of diffusion tensor imaging studies S Mohammadi, A Jahanshahi, MA Salehi, R Darvishi, H Seyedmirzaei, ... Addictive Behaviors 143, 107690, 2023 | 9 | 2023 |
Exploring the application of immunotherapy against HIV infection in the setting of malignancy: A detailed review article R Makuku, H Seyedmirzaei, MM Tantuoyir, E Rodríguez-Román, ... International Immunopharmacology 105, 108580, 2022 | 9 | 2022 |
Stem cell transplantation as a progressing treatment for retinitis pigmentosa S Hosseini Shabanan, H Seyedmirzaei, A Barnea, S Hanaei, N Rezaei Cell and Tissue Research, 1-29, 2022 | 9 | 2022 |
Microstructural white matter alterations associated with social anxiety disorders: A systematic review M Parsaei, SM Hasehmi, H Seyedmirzaei, G Cattarinussi, F Sambataro, ... Journal of Affective Disorders, 2024 | 8 | 2024 |
Recent progress in immunotherapy of breast cancer targeting the human epidermal growth factor receptor 2 (HER2) H Seyedmirzaei, M Keshavarz-Fathi, S Razi, M Gity, N Rezaei Journal of Oncology Pharmacy Practice 27 (5), 1235-1244, 2021 | 6 | 2021 |
Advanced nanoparticle strategies for optimizing RNA therapeutic delivery in neurodegenerative disorders N Naimi, H Seyedmirzaei, Z Hassannejad, AS Khaboushan Biomedicine & Pharmacotherapy 175, 116691, 2024 | 5 | 2024 |
Electroencephalographic findings post‐COVID‐19 vaccination: A systematic review of case reports and case series A Fazlollahi, M Zahmatyar, A Shamekh, A Motamedi, F Seyedi, ... Reviews in Medical Virology 33 (6), e2484, 2023 | 5 | 2023 |
A systematic review, meta-analysis, and network analysis of diagnostic microRNAs in glaucoma M Rezaei, M Faramarzpour, P Shobeiri, H Seyedmirzaei, MS Sarasyabi, ... European Journal of Medical Research 28 (1), 137, 2023 | 5 | 2023 |
Risk of MS relapse and deterioration after COVID-19: A systematic review and meta-analysis H Seyedmirzaei, D Salabat, S KamaliZonouzi, AL Teixeira, N Rezaei Multiple Sclerosis and Related Disorders, 105472, 2024 | 4 | 2024 |
Effects of COVID-19 pandemic on depression in patients with schizophrenia: A mini-review of the current evidence H Seyedmirzaei, S Katebian, D Pourkand, G Cattarinussi, F Sambataro, ... Journal of affective disorders 332, 143-149, 2023 | 4 | 2023 |
Cilostazol as adjunctive therapy in treatment of children with autism spectrum disorders: a double-blind and placebo-controlled randomized trial P Ebrahimi, H Seyedmirzaei, K Moradi, S Bagheri, M Moeini, ... International Clinical Psychopharmacology, 2022 | 4 | 2022 |
Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer’s disease: a longitudinal study F Nabizadeh, H Seyedmirzaei, S Karami Scientific Reports 14 (1), 15318, 2024 | 3 | 2024 |